Francesca Varrone
Regulus Therapeutics (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, MicroRNA in disease regulation, Epigenetics and DNA Methylation, Circular RNAs in diseases, Cancer-related gene regulation
Most-Cited Works
- → Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological Conditions(2009)394 cited
- → The miRNAs Role in Melanoma and in Its Resistance to Therapy(2020)76 cited
- → The Circulating Level of FABP3 Is an Indirect Biomarker of MicroRNA-1(2012)66 cited
- → Collagen Prolyl Hydroxylation–Dependent Metabolic Perturbation Governs Epigenetic Remodeling and Mesenchymal Transition in Pluripotent and Cancer Cells(2019)56 cited
- → Inhibition of Tat activity by the HEXIM1 protein(2005)33 cited
- → 6-Bromoindirubin-3′-oxime intercepts GSK3 signaling to promote and enhance skeletal muscle differentiation affecting miR-206 expression in mice(2019)27 cited
- → p14ARF directly interacts with Myc through the Myc BoxII domain(2006)18 cited
- → Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?(2021)11 cited
- → Activation of P-TEFb Induces p21 Leading to Cell Cycle Arrest(2007)7 cited
- → Cripto Is Targeted by miR-1a-3p in a Mouse Model of Heart Development(2023)2 cited